Skip to content
★ Sign in to follow
노보

노보믹스 Stock: price and insider trades · South Korea

No insider purchase over the last 90 days. The latest, by 허용민, was filed 28 Nov 2024.

노보믹스: what insiders have been doing

Every trade that managers of 노보믹스 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. The past year has been quiet: not a single insider filing for 노보믹스. The previous disclosure was published on 28 November 2024.

Source: insider filings from DART (FSS). Past trades are no guide to future returns.

Insider Decl.
9
Thresholds
n/a
Buy Volume
n/a
9 ops. · all time
Sell Volume
n/a
n/a

Financial data

· cache

Last declaration on 28 November 2024
Declarations9 total
  • ▲
    대표이사Executives
    0DART
    ShareKRXDART:20241128000970
    Canonical exit: 20 Feb 2025 (T+90)
  • ▲
    총괄경영사장Executives
    0DART
    ShareKRXDART:20241128000995
    Canonical exit: 20 Feb 2025 (T+90)
  • ▲
    Executives
    0DART
    331,126 sharesKRXDART:20241128000485
    Canonical exit: 20 Feb 2025 (T+90)
  • ▲
    총괄경영사장Executives(filed)
    0DART
    ShareKRXDART:20230426000501
    Canonical exit: 25 Jul 2023 (T+90)
  • ▲
    총괄경영사장Executives
    0DART
    ShareKRXDART:20230426000490
    Canonical exit: 18 Jul 2023 (T+90)
  • ▲
    총괄경영사장Executives
    0DART
    ShareKRXDART:20230426000480
    Canonical exit: 18 Jul 2023 (T+90)
  • ▲
    Executives(filed)
    0DART
    331,126 sharesKRXDART:20230426000426
    Canonical exit: 25 Jul 2023 (T+90)
  • ▲
    Executives
    0DART
    331,126 sharesKRXDART:20230426000151
    Canonical exit: 18 Jul 2023 (T+90)
  • ▲
    Executives(filed)
    0DART
    331,126 sharesKRXDART:20230425000196
    Canonical exit: 24 Jul 2023 (T+90)

9 of 9 declarations

About 노보믹스

Novomix is a company listed on the XKRX market, specializing in the health and pharmaceutical sector. It focuses on the development and commercialization of innovative pharmaceutical products.